Results 261 to 270 of about 10,512,482 (403)

P187 MRI T2 relaxometry to image fibrosis in patients with Crohn's disease [PDF]

open access: bronze, 2014
Christine Breynaert   +13 more
openalex   +1 more source

Pyoderma Gangrenosum: A Retrospective Cohort Study of Comorbidities and Therapies in Over 65,000 Patients in the TriNetX Database

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis associated with systemic inflammatory diseases and malignancy. Although biologic therapies demonstrate efficacy in PG, the extent of their real‐world use remains incompletely characterized.
Rhiannon Grange   +4 more
wiley   +1 more source

Nail Disorders in Systemic Conditions

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley   +1 more source

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]

open access: yesJGH Open
Qtaishat FA   +12 more
europepmc   +1 more source

Emotional Disturbances and Crohn's Disease. [PDF]

open access: yesClin Pract Epidemiol Ment Health
Lastretti M   +5 more
europepmc   +1 more source

Su1924 Small Bowel Capsule Endoscopy for Assessing Early Postoperative Recurrence of Crohn's Disease: A Prospective Longitudinal Study

open access: bronze, 2012
G. Condino   +8 more
openalex   +1 more source

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

open access: yesJournal of Crohn's & Colitis, 2006
G. Van Assche   +13 more
semanticscholar   +1 more source

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy